{
    "2021-04-02": [
        [
            {
                "time": "",
                "original_text": "[路演]沃森生物：预计mRNA新冠疫苗年内投产使用 设计产能1.2亿剂",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "mRNA",
                        "新冠疫苗",
                        "投产",
                        "设计产能",
                        "1.2亿剂"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[路演]沃森生物：预判新冠疫苗今明两年具有较好市场需求",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "新冠疫苗",
                        "市场需求",
                        "今明两年"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}